IP Library Granted Patent US 8,193,347
Granted Patent B2
US 8,193,347 · App. 12/282,399 · Granted Jun 5, 2012

Metal complexes of tetraazamacrocycle derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,193,347
App. No.
12/282,399
Granted
Jun 5, 2012
Kind
B2
Abstract

Improved methods for synthesizing bifunctional chelates of tetraazamacrocycle derivatives and intermediates thereof are disclosed as well as novel tetraazamacrocycle derivatives and intermediates thereof.

Claims (15)

1. A process for alkylating the free macrocyclic nitrogen of a trisalkylated tetraazamacrocycle of Formula 1 to yield a compound of Formula 2, the process comprising alkylating the free macrocyclic nitrogen with an alkylating agent, R 4 Y, in an organic solvent in the presence of a weak base

wherein the weak base comprises a metal ion M, R 1 , R 2 and R 3 are independently hydrocarbyl, substituted hydrocarbyl or heterocyclo; R 4 is optionally substituted, alkyl or aryl, X is a counterion; and Y is a leaving group.

2. The process according to claim 1 wherein M is selected from alkali metals, alkaline earth metals, transition metals and the lanthanides; R 1 , R 2 and R 3 are independently hydrocarbyl, substituted hydrocarbyl or heterocyclo; R 4 is an optionally substituted alkyl, aryl or acyl; X comprises halides, nitrates, sulfates or phosphates; and Y comprises the halides, methanesulfonate, trifluoroacetate, trifluormethanesulfonate or p-toluene-sulfonate.

3. The process according to claim 1 wherein R 1 , R 2 and R 3 are independently selected from the group consisting of —CH 2 CO 2 R 5 , —CH 2 ArOR 5 , —CH 2 SR 5 , —CH 2 PO 3 H 2 , —CH 2 SO 3 H, —CH 2 Ar(OR 5 ) 2 , —CH 2 Ar(OR 5 )R 6 and —CH 2 Ar(OR 5 ) 2 R 6 ; wherein R 5 and R 6 are independently H, t-Bu, Et, Me, benzyl or methoxybenzyl.

4. The process according to claim 1 wherein R 4 is —CH 2 ArOR 7 , —CH(R 8 )CO 2 R 7 , —CH 2 Ar(OR 7 ) 2 , —CH 2 Ar(OR 7 )R 8 , or —CH 2 Ar(OR 7 ) 2 R 8 ; R 7 is H, t-Bu, Et or Me; R 8 is selected from the group consisting of optionally substituted acyl, aryl and heteroaryl, alkoxy, hydroxy, halo, amino, nitro, thiols, disulfides, carbohydrates, vitamins, and combinations and derivatives thereof; and Ar is an optionally substituted phenyl, pyrimidinyl or pyridinyl.

5. The process according to claim 1 , wherein

R 1 , R 2 and R 3 are independently selected from the group consisting of —CH 2 CO 2 R 5 , —CH 2 ArOR 5 , —CH 2 SR 5 , —CH 2 PO 3 H 2 , —CH 2 SO 3 H, —CH 2 Ar(OR 5 ) 2 , —CH 2 Ar(OR 5 )R 6 and —CH 2 Ar(OR 5 ) 2 R 6 ;

R 4 is —CH 2 ArOR 7 , —CH(R 8 )CO 2 R 7 , —CH 2 Ar(OR 7 ) 2 , —CH 2 Ar(OR 7 )R 8 , or —CH 2 Ar(OR 7 ) 2 R 8 ;

R 5 , R 6 and R 7 are independently hydrogen, alkyl or substituted alkyl;

R 8 is selected from a group consisting of optionally substituted acyl, aryl and heteroaryl, alkoxy, hydroxy, halo, amino, nitro, thiols, disulfides, carbohydrates, vitamins, combinations and derivatives;

Ar is an optionally substituted phenyl, pyrimidinyl or pyridinyl; and

Y is a leaving group selected from the group consisting of bromide, chloride, iodide, methanesulfonate, trifluoroacetate, trifluormethanesulfonate and p-toluenesulfonate.

6. The process according to claim 5 wherein R 1 , R 2 and R 3 are independently —CH 2 CO 2 R 5 ; and R 5 is H, t-Bu, Et, Me, benzyl or benzylmethoxy.

7. The process according to claim 5 wherein R 4 is —CH 2 Ar(OR 5 )NO 2 or —CH(CO 2 R 5 )—(CH 2 ) 4 NHCO 2 CH 2 Ar.

8. The process according to claim 7 wherein Ar is phenyl, M is sodium and Y is bromide.

Assignments (4)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
SECURITY INTEREST Recorded Mar 19, 2014
From: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS INC.; MALLINCKRODT CARIBBEAN, INC.; MALLINCKRODT US POOL LLC; MALLINCKRODT INC.; LUDLOW CORPORATION; CNS THERAPEUTICS, INC.; ENTERPRISES HOLDINGS, INC.; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS, INC; MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC; MALLINCKRODT ENTERPRISES HOLDINGS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 032480/0001 →
CHANGE OF LEGAL ENTITY Recorded Aug 16, 2011
From: MALLINCKRODT INC.
To: MALLINCKRODT LLC
Reel/Frame 026754/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2008
From: MOORE, DENNIS A.
To: MALLINCKRODT INC.
Reel/Frame 021507/0731 →